Breaking News Instant updates and real-time market news.

FBIO

Fortress Biotech

$2.87 /

-0.005 (-0.17%)

07:50
07/29/20
07/29
07:50
07/29/20
07:50

Fortress Biotech announces publication of study on prevalence of Menkes disease

Fortress Biotech announced the publication of a study, "Targeted Next Generation Sequencing for Newborn Screening of Menkes Disease" in Molecular Genetics and Metabolism Reports. The study was published online in July 2020. The study assessed the analytic validity of an ATP7A targeted next generation DNA sequencing assay as a potential newborn screen for Menkes disease, a X-linked recessive disorder of copper metabolism caused by mutations in ATP7A, an evolutionarily conserved copper-transporting ATPase. Left undetected and untreated, Menkes disease is often fatal by three years of age. Population-based newborn screening allows early detection and treatment of inherited disorders. For certain medically-actionable conditions, however, NBS is limited by the absence of reliable biochemical signatures amenable to detection by current platforms. In the study, supported in part by The Menkes Foundation and led by Stephen G. Kaler, M.D., M.P.H., a physician-scientist in the Center for Gene Therapy in the Abigail Wexner Research Institute at Nationwide Children's Hospital, researchers blindly analyzed dried blood spots from control or Menkes disease subjects for pathogenic variants in the copper transporter gene, ATP7A. The analytical method was optimized to minimize cost and provide rapid turnaround time. The algorithm correctly identified pathogenic ATP7A variants, including missense, nonsense, small insertions/deletions, and large copy number variants, in 21/22 of subjects, one of whom had inconclusive diagnostic sequencing previously. For one false negative that also had not been detected by commercial molecular laboratories, researchers identified a deep intronic variant that impaired ATP7A mRNA splicing.

FBIO Fortress Biotech
$2.87 /

-0.005 (-0.17%)

04/13/20 B. Riley FBR
AstraZeneca study halt has positive read-through to Fortress, says B. Riley FBR
02/13/20
Fly Intel: Top five analyst initiations
02/12/20 Cantor Fitzgerald
Fortress Biotech initiated with an Overweight at Cantor Fitzgerald
12/18/19 B. Riley FBR
Fortress Biotech initiated with a Buy at B. Riley FBR

TODAY'S FREE FLY STORIES

Options
Hertz options imply 23.9% move in share price post-earnings » 15:19
08/10/20
08/10
15:19
08/10/20
15:19
HTZ

Hertz

$1.69 /

+0.165 (+10.86%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HTZ Hertz
$1.69 /

+0.165 (+10.86%)

HTZ Hertz
$1.69 /

+0.165 (+10.86%)

06/24/20 Jefferies
CarMax, AutoNation could be eyeing Hertz in bankruptcy, says Jefferies
05/05/20 Morgan Stanley
2020 may not be quite as bad as feared for used cars, says Morgan Stanley
04/27/20
Fly Intel: Top five analyst downgrades
04/27/20 Barclays
Barclays downgrades Hertz to Underweight on risk of capital call
HTZ Hertz
$1.69 /

+0.165 (+10.86%)

HTZ Hertz
$1.69 /

+0.165 (+10.86%)

HTZ Hertz
$1.69 /

+0.165 (+10.86%)

HTZ Hertz
$1.69 /

+0.165 (+10.86%)

Recommendations
Amarin Perform rating affirmed at Oppenheimer after FDA approves Vascepa generic » 15:18
08/10/20
08/10
15:18
08/10/20
15:18
AMRN

Amarin

$6.96 /

-0.03 (-0.43%)

, RDY

Dr. Reddy's

$62.06 /

+1.75 (+2.90%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMRN Amarin
$6.96 /

-0.03 (-0.43%)

RDY Dr. Reddy's
$62.06 /

+1.75 (+2.90%)

AMRN Amarin
$6.96 /

-0.03 (-0.43%)

06/17/20 SVB Leerink
Amarin doubling down on appeal after settlement with Apotex, says SVB Leerink
06/17/20 Stifel
Amarin settlement with Apotex an 'incremental positive,' says Stifel
06/08/20 Jefferies
Jefferies sees growing reasons to believe Amarin may win Vascepa appeal
05/22/20 Roth Capital
Roth Capital says buy Amarin as at-risk generic launch unlikely
RDY Dr. Reddy's
$62.06 /

+1.75 (+2.90%)

07/30/20 Barclays
Dr. Reddy's price target raised to $53 from $45 at Barclays
06/17/20 SVB Leerink
Amarin doubling down on appeal after settlement with Apotex, says SVB Leerink
06/17/20 Stifel
Amarin settlement with Apotex an 'incremental positive,' says Stifel
04/21/20 Nomura Instinet
Dr. Reddy's price target raised to INR 4,426 from INR 3,684
AMRN Amarin
$6.96 /

-0.03 (-0.43%)

RDY Dr. Reddy's
$62.06 /

+1.75 (+2.90%)

AMRN Amarin
$6.96 /

-0.03 (-0.43%)

AMRN Amarin
$6.96 /

-0.03 (-0.43%)

RDY Dr. Reddy's
$62.06 /

+1.75 (+2.90%)

AMRN Amarin
$6.96 /

-0.03 (-0.43%)

Technical Analysis
NASDAQ market internals summary » 15:17
08/10/20
08/10
15:17
08/10/20
15:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 15:16
08/10/20
08/10
15:16
08/10/20
15:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Periodicals
EPA to overturn methane regulations for oil and gas, WSJ says » 15:13
08/10/20
08/10
15:13
08/10/20
15:13
BP

BP

$23.41 /

+0.435 (+1.89%)

, COP

ConocoPhillips

$39.57 /

+1.255 (+3.28%)

, TOT

Total

$39.20 /

+0.25 (+0.64%)

, XOM

Exxon Mobil

$44.29 /

+0.84 (+1.93%)

, CVX

Chevron

$89.40 /

+2.59 (+2.98%)

, RDS.A

Royal Dutch Shell

$31.38 /

+0.53 (+1.72%)

The EPA is about to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BP BP
$23.41 /

+0.435 (+1.89%)

COP ConocoPhillips
$39.57 /

+1.255 (+3.28%)

TOT Total
$39.20 /

+0.25 (+0.64%)

XOM Exxon Mobil
$44.29 /

+0.84 (+1.93%)

CVX Chevron
$89.40 /

+2.59 (+2.98%)

RDS.A Royal Dutch Shell
$31.38 /

+0.53 (+1.72%)

BP BP
$23.41 /

+0.435 (+1.89%)

08/05/20 Credit Suisse
BP price target raised to 400 GBp from 350 GBp at Credit Suisse
08/05/20 RBC Capital
BP price target raised to 290 GBp from 250 GBp at RBC Capital
08/05/20 Evercore ISI
BP downgraded to In Line after dividend reset at Evercore ISI
08/05/20 Evercore ISI
BP downgraded to In Line from Outperform at Evercore ISI
COP ConocoPhillips
$39.57 /

+1.255 (+3.28%)

08/04/20 Credit Suisse
ConocoPhillips assumed with an Outperform at Credit Suisse
07/23/20 SunTrust
SunTrust starts ConocoPhillips with Buy rating, $51 price target
07/23/20 SunTrust
ConocoPhillips initiated with a Buy at SunTrust
06/19/20 Mizuho
ConocoPhillips price target raised to $46 from $37 at Mizuho
TOT Total
$39.20 /

+0.25 (+0.64%)

08/03/20 Berenberg
Berenberg backs Buy on Total
07/31/20 Morgan Stanley
Total upgraded to Overweight from Equal Weight at Morgan Stanley
07/31/20 Morgan Stanley
Total upgraded to Overweight from Equal Weight at Morgan Stanley
07/16/20
Fly Intel: Top five analyst initiations
XOM Exxon Mobil
$44.29 /

+0.84 (+1.93%)

07/23/20 SunTrust
SunTrust starts Exxon with Hold rating, $41 price target
07/23/20 SunTrust
Exxon Mobil initiated with a Hold at SunTrust
06/09/20 Standpoint Research
Exxon Mobil downgraded to Hold from Buy at Standpoint Research
06/09/20 JPMorgan
Exxon Mobil price target raised to $51 from $44 at JPMorgan
CVX Chevron
$89.40 /

+2.59 (+2.98%)

08/04/20 Truist
Noble Energy downgraded to Hold from Buy at Truist
08/03/20 Stifel
Noble Energy downgraded to Hold from Buy at Stifel
07/23/20 SunTrust
SunTrust starts Chevron with Buy rating, $120 price target
07/23/20 SunTrust
Chevron initiated with a Buy at SunTrust
RDS.A Royal Dutch Shell
$31.38 /

+0.53 (+1.72%)

08/03/20 Berenberg
Royal Dutch Shell price target raised to EUR 17 from EUR 16.70 at Berenberg
07/15/20 JPMorgan
Royal Dutch Shell price target raised to 1,700 GBp from 1,650 GBp at JPMorgan
07/13/20 Citi
'Long-road back' for Shell to win back investor trust, says Citi
06/15/20 UBS
Royal Dutch Shell price target raised to 1,750 GBp from 1,650 GBp at UBS
BP BP
$23.41 /

+0.435 (+1.89%)

COP ConocoPhillips
$39.57 /

+1.255 (+3.28%)

TOT Total
$39.20 /

+0.25 (+0.64%)

XOM Exxon Mobil
$44.29 /

+0.84 (+1.93%)

CVX Chevron
$89.40 /

+2.59 (+2.98%)

RDS.A Royal Dutch Shell
$31.38 /

+0.53 (+1.72%)

BP BP
$23.41 /

+0.435 (+1.89%)

COP ConocoPhillips
$39.57 /

+1.255 (+3.28%)

TOT Total
$39.20 /

+0.25 (+0.64%)

XOM Exxon Mobil
$44.29 /

+0.84 (+1.93%)

CVX Chevron
$89.40 /

+2.59 (+2.98%)

RDS.A Royal Dutch Shell
$31.38 /

+0.53 (+1.72%)

BP BP
$23.41 /

+0.435 (+1.89%)

COP ConocoPhillips
$39.57 /

+1.255 (+3.28%)

TOT Total
$39.20 /

+0.25 (+0.64%)

XOM Exxon Mobil
$44.29 /

+0.84 (+1.93%)

CVX Chevron
$89.40 /

+2.59 (+2.98%)

RDS.A Royal Dutch Shell
$31.38 /

+0.53 (+1.72%)

BP BP
$23.41 /

+0.435 (+1.89%)

COP ConocoPhillips
$39.57 /

+1.255 (+3.28%)

TOT Total
$39.20 /

+0.25 (+0.64%)

XOM Exxon Mobil
$44.29 /

+0.84 (+1.93%)

CVX Chevron
$89.40 /

+2.59 (+2.98%)

Hot Stocks
Berkshire Hills Bancorp trading resumes  15:13
08/10/20
08/10
15:13
08/10/20
15:13
BHLB

Berkshire Hills Bancorp

$10.87 /

+0.43 (+4.12%)

 
ShowHide Related Items >><<
BHLB Berkshire Hills Bancorp
$10.87 /

+0.43 (+4.12%)

BHLB Berkshire Hills Bancorp
$10.87 /

+0.43 (+4.12%)

08/03/20 DA Davidson
Berkshire Hills Bancorp upgraded to Buy from Neutral at DA Davidson
08/03/20 DA Davidson
Berkshire Hills Bancorp upgraded to Buy from Neutral at DA Davidson
06/12/20 Piper Sandler
Berkshire Hills Bancorp upgraded to Overweight from Neutral at Piper Sandler
05/06/20 Compass Point
Berkshire Hills Bancorp downgraded to Sell from Neutral at Compass Point
BHLB Berkshire Hills Bancorp
$10.87 /

+0.43 (+4.12%)

Options
Ideanomics options imply 41.6% move in share price post-earnings » 15:04
08/10/20
08/10
15:04
08/10/20
15:04
IDEX

Ideanomics

$1.82 /

+0.18 (+11.01%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IDEX Ideanomics
$1.82 /

+0.18 (+11.01%)

IDEX Ideanomics
$1.82 /

+0.18 (+11.01%)

IDEX Ideanomics
$1.82 /

+0.18 (+11.01%)

IDEX Ideanomics
$1.82 /

+0.18 (+11.01%)

Hot Stocks
Berkshire Hills Bancorp names Gray as acting CEO after Marotta steps down » 15:02
08/10/20
08/10
15:02
08/10/20
15:02
BHLB

Berkshire Hills Bancorp

$10.87 /

+0.43 (+4.12%)

Berkshire Hills Bancorp,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHLB Berkshire Hills Bancorp
$10.87 /

+0.43 (+4.12%)

BHLB Berkshire Hills Bancorp
$10.87 /

+0.43 (+4.12%)

08/03/20 DA Davidson
Berkshire Hills Bancorp upgraded to Buy from Neutral at DA Davidson
08/03/20 DA Davidson
Berkshire Hills Bancorp upgraded to Buy from Neutral at DA Davidson
06/12/20 Piper Sandler
Berkshire Hills Bancorp upgraded to Overweight from Neutral at Piper Sandler
05/06/20 Compass Point
Berkshire Hills Bancorp downgraded to Sell from Neutral at Compass Point
BHLB Berkshire Hills Bancorp
$10.87 /

+0.43 (+4.12%)

Recommendations
Gogo price target raised to $8 from $7 at Roth Capital » 15:00
08/10/20
08/10
15:00
08/10/20
15:00
GOGO

Gogo

$3.54 /

+0.29 (+8.92%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOGO Gogo
$3.54 /

+0.29 (+8.92%)

GOGO Gogo
$3.54 /

+0.29 (+8.92%)

07/07/20 Roth Capital
Roth Capital still bullish on Gogo, says new 3k foot floor highlights BA value
03/13/20 William Blair
Delta dual sourcing Wi-Fi potentially positive for ViaSat, says William Blair
03/02/20 William Blair
Gogo estimates lowered travel disruption from COVID-19 at William Blair
10/01/19 Morgan Stanley
Free WiFi poses Gogo risks, presents ViaSat opportunity, says Morgan Stanley
GOGO Gogo
$3.54 /

+0.29 (+8.92%)

GOGO Gogo
$3.54 /

+0.29 (+8.92%)

GOGO Gogo
$3.54 /

+0.29 (+8.92%)

Conference/Events
Goldman Euro semi & commtech analyst holds analyst/industry conference call » 14:54
08/10/20
08/10
14:54
08/10/20
14:54

European Semiconductor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Options
Inovio options imply 25.5% move in share price post-earnings » 14:49
08/10/20
08/10
14:49
08/10/20
14:49
INO

Inovio

$18.78 /

-1.445 (-7.15%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INO Inovio
$18.78 /

-1.445 (-7.15%)

INO Inovio
$18.78 /

-1.445 (-7.15%)

07/01/20
Fly Intel: Top five analyst downgrades
07/01/20 Maxim
Inovio downgraded to Hold from Buy at Maxim
07/01/20 Roth Capital
Roth 'unimpressed' with Inovio data, downgrades to Sell with $11 target
07/01/20 Maxim
Inovio downgraded to Hold from Buy at Maxim
INO Inovio
$18.78 /

-1.445 (-7.15%)

INO Inovio
$18.78 /

-1.445 (-7.15%)

INO Inovio
$18.78 /

-1.445 (-7.15%)

INO Inovio
$18.78 /

-1.445 (-7.15%)

Periodicals
Lucid Motors says $100,000 luxury EV will have 440 +mile range, BI says » 14:47
08/10/20
08/10
14:47
08/10/20
14:47
TSLA

Tesla

$1,417.00 /

-35.81 (-2.46%)

, NIO

NIO Inc.

$14.06 /

+0.64 (+4.77%)

, NKLA

Nikola

$44.40 /

+7.68 (+20.92%)

, FUV

Arcimoto

$6.75 /

+0.08 (+1.20%)

, KNDI

Kandi Technologies

$9.05 /

-0.04 (-0.44%)

Lucid Motors will reveal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$1,417.00 /

-35.81 (-2.46%)

NIO NIO Inc.
$14.06 /

+0.64 (+4.77%)

NKLA Nikola
$44.40 /

+7.68 (+20.92%)

FUV Arcimoto
$6.75 /

+0.08 (+1.20%)

KNDI Kandi Technologies
$9.05 /

-0.04 (-0.44%)

TSLA Tesla
$1,417.00 /

-35.81 (-2.46%)

08/05/20 Piper Sandler
Piper calls Beyond Meat the Tesla of packaged food, ups price target
07/29/20 Morgan Stanley
Tesla price target raised to $1,050 from $740 at Morgan Stanley
07/28/20
Fly Intel: Top five analyst downgrades
07/28/20 Bernstein
Bernstein's Sacconaghi downgrades Tesla to sell on 'mind-boggling' valuation
NIO NIO Inc.
$14.06 /

+0.64 (+4.77%)

07/21/20 CICC
NIO Inc. upgraded to Outperform from Neutral at CICC
07/17/20
Fly Intel: Top five analyst downgrades
07/17/20 Goldman Sachs
NIO Inc. downgraded to Sell from Neutral at Goldman Sachs
07/16/20 Deutsche Bank
Nikola initiated with a Hold at Deutsche Bank
NKLA Nikola
$44.40 /

+7.68 (+20.92%)

08/05/20 Deutsche Bank
Nikola near-term setup remains favorable, says Deutsche Bank
08/05/20 JPMorgan
Nikola shares may fall on 'non-news' Q2 results, says JPMorgan
08/03/20 Deutsche Bank
Nikola named short-term buy ahead of results at Deutsche Bank
07/20/20 Deutsche Bank
Nikola filing may bring 'large technical selling pressure,' says Deutsche Bank
FUV Arcimoto
$6.75 /

+0.08 (+1.20%)

06/25/20 Aegis
Arcimoto initiated with a Buy at Aegis
06/15/20 Roth Capital
Arcimoto price target raised to $5 from $3 at Roth Capital
12/12/19 Dougherty
Arcimoto initiated with a Buy at Dougherty
09/06/19 H.C. Wainwright
Arcimoto initiated with a Buy at H.C. Wainwright
KNDI Kandi Technologies
$9.05 /

-0.04 (-0.44%)

TSLA Tesla
$1,417.00 /

-35.81 (-2.46%)

NIO NIO Inc.
$14.06 /

+0.64 (+4.77%)

NKLA Nikola
$44.40 /

+7.68 (+20.92%)

FUV Arcimoto
$6.75 /

+0.08 (+1.20%)

KNDI Kandi Technologies
$9.05 /

-0.04 (-0.44%)

  • 11
    Jun
  • 14
    Feb
  • 22
    Nov
TSLA Tesla
$1,417.00 /

-35.81 (-2.46%)

NIO NIO Inc.
$14.06 /

+0.64 (+4.77%)

NKLA Nikola
$44.40 /

+7.68 (+20.92%)

TSLA Tesla
$1,417.00 /

-35.81 (-2.46%)

NIO NIO Inc.
$14.06 /

+0.64 (+4.77%)

NKLA Nikola
$44.40 /

+7.68 (+20.92%)

FUV Arcimoto
$6.75 /

+0.08 (+1.20%)

KNDI Kandi Technologies
$9.05 /

-0.04 (-0.44%)

TSLA Tesla
$1,417.00 /

-35.81 (-2.46%)

NIO NIO Inc.
$14.06 /

+0.64 (+4.77%)

NKLA Nikola
$44.40 /

+7.68 (+20.92%)

FUV Arcimoto
$6.75 /

+0.08 (+1.20%)

KNDI Kandi Technologies
$9.05 /

-0.04 (-0.44%)

Hot Stocks
Berkshire Hills Bancorp trading halted, news pending  14:45
08/10/20
08/10
14:45
08/10/20
14:45
BHLB

Berkshire Hills Bancorp

$10.91 /

+0.47 (+4.50%)

 
ShowHide Related Items >><<
BHLB Berkshire Hills Bancorp
$10.91 /

+0.47 (+4.50%)

BHLB Berkshire Hills Bancorp
$10.91 /

+0.47 (+4.50%)

08/03/20 DA Davidson
Berkshire Hills Bancorp upgraded to Buy from Neutral at DA Davidson
08/03/20 DA Davidson
Berkshire Hills Bancorp upgraded to Buy from Neutral at DA Davidson
06/12/20 Piper Sandler
Berkshire Hills Bancorp upgraded to Overweight from Neutral at Piper Sandler
05/06/20 Compass Point
Berkshire Hills Bancorp downgraded to Sell from Neutral at Compass Point
BHLB Berkshire Hills Bancorp
$10.91 /

+0.47 (+4.50%)

Options
 » 14:45
08/10/20
08/10
14:45
08/10/20
14:45

Trading halted (News…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Periodicals
Exxon Beaumont union workers seek negotiations over 401k change, Reuters says » 14:45
08/10/20
08/10
14:45
08/10/20
14:45
XOM

Exxon Mobil

$44.29 /

+0.84 (+1.93%)

Unionized workers at…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XOM Exxon Mobil
$44.29 /

+0.84 (+1.93%)

XOM Exxon Mobil
$44.29 /

+0.84 (+1.93%)

07/23/20 SunTrust
SunTrust starts Exxon with Hold rating, $41 price target
07/23/20 SunTrust
Exxon Mobil initiated with a Hold at SunTrust
06/09/20 Standpoint Research
Exxon Mobil downgraded to Hold from Buy at Standpoint Research
06/09/20 JPMorgan
Exxon Mobil price target raised to $51 from $44 at JPMorgan
XOM Exxon Mobil
$44.29 /

+0.84 (+1.93%)

XOM Exxon Mobil
$44.29 /

+0.84 (+1.93%)

XOM Exxon Mobil
$44.29 /

+0.84 (+1.93%)

XOM Exxon Mobil
$44.29 /

+0.84 (+1.93%)

Options
Sunrun call volume above normal and directionally bullish » 14:45
08/10/20
08/10
14:45
08/10/20
14:45
RUN

Sunrun

$47.41 /

+1.41 (+3.07%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RUN Sunrun
$47.41 /

+1.41 (+3.07%)

RUN Sunrun
$47.41 /

+1.41 (+3.07%)

07/27/20 Roth Capital
Sunnova Energy price target raised to $28 from $22 at Roth Capital
07/22/20 Barclays
Sunrun price target raised to $50 from $23 at Barclays
07/13/20 KeyBanc
Vivint Solar price target raised to $18 from $12 at KeyBanc
07/13/20 KeyBanc
KeyBanc upgrades Sunrun to Overweight on Vivint merger
RUN Sunrun
$47.41 /

+1.41 (+3.07%)

RUN Sunrun
$47.41 /

+1.41 (+3.07%)

RUN Sunrun
$47.41 /

+1.41 (+3.07%)

Recommendations
Reata Pharmaceuticals price target lowered to $225 from $280 at Stifel » 14:44
08/10/20
08/10
14:44
08/10/20
14:44
RETA

Reata Pharmaceuticals

$105.22 /

-51.94 (-33.05%)

Stifel analyst Annabel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RETA Reata Pharmaceuticals
$105.22 /

-51.94 (-33.05%)

RETA Reata Pharmaceuticals
$105.22 /

-51.94 (-33.05%)

12:56 Today BTIG
Reata adds uncertainty with 'long-awaited' updates, says BTIG
12:54 Today Jefferies
Reata Pharmaceuticals overreaction creates buying opportunity, says Jefferies
07/10/20 Stifel
Reata transferred with Buy rating, removed from Select List at Stifel
06/16/20 BTIG
Reata Pharmaceuticals initiated with a Buy at BTIG
RETA Reata Pharmaceuticals
$105.22 /

-51.94 (-33.05%)

  • 14
    Nov
RETA Reata Pharmaceuticals
$105.22 /

-51.94 (-33.05%)

RETA Reata Pharmaceuticals
$105.22 /

-51.94 (-33.05%)

Recommendations
Ceva price target raised to $60 from $50 at Roth Capital » 14:38
08/10/20
08/10
14:38
08/10/20
14:38
CEVA

Ceva

$45.15 /

+3.14 (+7.47%)

Roth Capital analyst Suji…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CEVA Ceva
$45.15 /

+3.14 (+7.47%)

CEVA Ceva
$45.15 /

+3.14 (+7.47%)

07/16/20 Roth Capital
Ceva price target raised to $50 from $40 at Roth Capital
06/04/20 Northland
Ceva downgraded to Market Perform from Outperform at Northland
03/30/20 Northland
Ceva upgraded to Outperform from Market Perform at Northland
02/18/20 Roth Capital
Ceva price target raised to $40 from $35 at Roth Capital
CEVA Ceva
$45.15 /

+3.14 (+7.47%)

Hot Stocks
Dr. Reddy's receives FDA approval for generic version of Icosapent Ethyl » 14:34
08/10/20
08/10
14:34
08/10/20
14:34
RDY

Dr. Reddy's

$62.07 /

+1.76 (+2.92%)

, AMRN

Amarin

$7.13 /

+0.14 (+2.00%)

Icosapent Ethyl is sold…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDY Dr. Reddy's
$62.07 /

+1.76 (+2.92%)

AMRN Amarin
$7.13 /

+0.14 (+2.00%)

RDY Dr. Reddy's
$62.07 /

+1.76 (+2.92%)

07/30/20 Barclays
Dr. Reddy's price target raised to $53 from $45 at Barclays
06/17/20 SVB Leerink
Amarin doubling down on appeal after settlement with Apotex, says SVB Leerink
06/17/20 Stifel
Amarin settlement with Apotex an 'incremental positive,' says Stifel
04/21/20 Nomura Instinet
Dr. Reddy's price target raised to INR 4,426 from INR 3,684
AMRN Amarin
$7.13 /

+0.14 (+2.00%)

06/17/20 SVB Leerink
Amarin doubling down on appeal after settlement with Apotex, says SVB Leerink
06/17/20 Stifel
Amarin settlement with Apotex an 'incremental positive,' says Stifel
06/08/20 Jefferies
Jefferies sees growing reasons to believe Amarin may win Vascepa appeal
05/22/20 Roth Capital
Roth Capital says buy Amarin as at-risk generic launch unlikely
RDY Dr. Reddy's
$62.07 /

+1.76 (+2.92%)

AMRN Amarin
$7.13 /

+0.14 (+2.00%)

AMRN Amarin
$7.13 /

+0.14 (+2.00%)

RDY Dr. Reddy's
$62.07 /

+1.76 (+2.92%)

AMRN Amarin
$7.13 /

+0.14 (+2.00%)

AMRN Amarin
$7.13 /

+0.14 (+2.00%)

Hot Stocks
Actinium Pharmaceuticals announces 1-for-30 reverse split of its common stock » 14:32
08/10/20
08/10
14:32
08/10/20
14:32
ATNM

Actinium Pharmaceuticals

$0.42 /

-0.0087 (-2.05%)

Actinium Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATNM Actinium Pharmaceuticals
$0.42 /

-0.0087 (-2.05%)

ATNM Actinium Pharmaceuticals
$0.42 /

-0.0087 (-2.05%)

06/04/20 H.C. Wainwright
Actinium Pharmaceuticals initiated with a Buy at H.C. Wainwright
04/17/20 JonesTrading
Key Actinium questions could be answered sooner than expected, says JonesTrading
  • 17
    Jun
  • 22
    Apr
ATNM Actinium Pharmaceuticals
$0.42 /

-0.0087 (-2.05%)

Recommendations
Siemens price target raised to EUR 125 from EUR 122 at Deutsche Bank » 14:29
08/10/20
08/10
14:29
08/10/20
14:29
SIEGY

Siemens

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SIEGY Siemens
$0.00 /

+ (+0.00%)

SIEGY Siemens
$0.00 /

+ (+0.00%)

08/07/20 Citi
Siemens price target raised to EUR 138 at Citi
08/07/20 JPMorgan
Siemens price target raised to EUR 126 from EUR 124 at JPMorgan
07/20/20 JPMorgan
Siemens price target raised to EUR 124 from EUR 112 at JPMorgan
07/17/20 Deutsche Bank
Siemens reinstated with a Buy at Deutsche Bank
SIEGY Siemens
$0.00 /

+ (+0.00%)

SIEGY Siemens
$0.00 /

+ (+0.00%)

Recommendations
Outokumpu price target lowered to EUR 3.30 from EUR 3.40 at Deutsche Bank » 14:29
08/10/20
08/10
14:29
08/10/20
14:29
OUTFF

Outokumpu

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OUTFF Outokumpu
$0.00 /

+ (+0.00%)

14:17 Today JPMorgan
Outokumpu price target lowered to EUR 2.10 from EUR 2.30 at JPMorgan
06/23/20 Morgan Stanley
Outokumpu price target raised to EUR 3 from EUR 2.90 at Morgan Stanley
Recommendations
Legal & General price target lowered to 285 GBp from 290 GBp at Deutsche Bank » 14:28
08/10/20
08/10
14:28
08/10/20
14:28
LGGNY

Legal & General

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LGGNY Legal & General
$0.00 /

+ (+0.00%)

08/07/20 Morgan Stanley
Legal & General upgraded to Equal Weight from Underweight at Morgan Stanley
07/15/20 Deutsche Bank
Legal & General price target lowered to 290 GBp from 295 GBp at Deutsche Bank
07/14/20 JPMorgan
Legal & General price target raised to 202 GBp from 200 GBp at JPMorgan
07/14/20 Morgan Stanley
Legal & General price target raised to 273 GBp from 265 GBp at Morgan Stanley
Recommendations
Eurofins Scientific price target raised to EUR 375 at Deutsche Bank » 14:27
08/10/20
08/10
14:27
08/10/20
14:27
ERFSF

Eurofins Scientific

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ERFSF Eurofins Scientific
$0.00 /

+ (+0.00%)

14:20 Today Credit Suisse
Eurofins Scientific price target raised to EUR 735 at Credit Suisse
05/27/20 Jefferies
Eurofins Scientific upgraded to Buy from Hold at Jefferies
03/11/20 Morgan Stanley
Eurofins Scientific upgraded to Equal Weight from Underweight at Morgan Stanley
02/14/20 Deutsche Bank
Eurofins Scientific initiated with a Sell at Deutsche Bank
Recommendations
Direct Line price target raised to 380 GBp from 350 GBp at Deutsche Bank » 14:26
08/10/20
08/10
14:26
08/10/20
14:26
DIISY

Direct Line Insurance

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DIISY Direct Line Insurance
$0.00 /

+ (+0.00%)

08/05/20 Citi
Direct Line Insurance price target raised to 342 GBp at Citi
07/13/20 JPMorgan
Direct Line Insurance results will focus on dividend outlook, says JPMorgan
06/23/20 Berenberg
Direct Line Insurance initiated with a Buy at Berenberg
06/11/20 Morgan Stanley
Direct Line price target raised to 330 GBp from 320 GBp at Morgan Stanley

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.